{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T12:10:09Z","timestamp":1776514209902,"version":"3.51.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10654-018-0454-0","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T03:47:49Z","timestamp":1540266469000},"page":"247-258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study"],"prefix":"10.1007","volume":"34","author":[{"name":"On behalf of the EUROASPIRE Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3202-7238","authenticated-orcid":false,"given":"Dirk","family":"De Bacquer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"De Smedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kornelia","family":"Kotseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viveca","family":"Gyberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahira","family":"Shahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Amouyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Bruthans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"Castro Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"C\u00edfkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap W.","family":"Deckers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"De Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirza","family":"Dilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryna","family":"Dolzhenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrejs","family":"Erglis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zlatko","family":"Fras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Gaita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Gotcheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Goudevenos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Heuschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandras","family":"Laucevicius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seppo","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragan","family":"Lovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davor","family":"Mili\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evagoras","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Oganov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Pajak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Pogosova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeljko","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Stagmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"St\u00f6rk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lale","family":"Tokg\u00f6zo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusko","family":"Vulic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,23]]},"reference":[{"key":"454_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ijcard.2016.12.125","volume":"232","author":"G Halewijn van","year":"2017","unstructured":"van Halewijn G, Deckers J, Tay HY, van Domburg R, Kotseva K, Wood D. Lessons from contemporary trials of cardiovascular prevention and rehabilitation: a systematic review and meta-analysis. Int J Cardiol. 2017;232:294\u2013303.","journal-title":"Int J Cardiol"},{"issue":"29","key":"454_CR2","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corr\u00e0 U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, L\u00f8chen ML, L\u00f6llgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM, Authors\/Task Force Members. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315\u201381.","journal-title":"Eur Heart J"},{"issue":"6","key":"454_CR3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/2047487315569401","volume":"23","author":"K Kotseva","year":"2016","unstructured":"Kotseva K, Wood D, De Bacquer D, De Backer G, Ryd\u00e9n L, Jennings C, Gyberg V, Amouyel P, Bruthans J, Castro Conde A, C\u00edfkov\u00e1 R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Mili\u010di\u0107 D, Moore D, Nicolaides E, Oganov R, Pajak A, Pogosova N, Reiner Z, Stagmo M, St\u00f6rk S, Tokg\u00f6zo\u011flu L, Vulic D, EUROASPIRE Investigators. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23(6):636\u201348.","journal-title":"Eur J Prev Cardiol"},{"issue":"13","key":"454_CR4","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"J Perk","year":"2012","unstructured":"Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syv\u00e4nne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, European Association for Cardiovascular Prevention & Rehabilitation (EACPR), ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice. The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635\u2013701.","journal-title":"Eur Heart J"},{"issue":"9","key":"454_CR5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"6","key":"454_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"A Zigmond","year":"1983","unstructured":"Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"454_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/HJR.0b013e32833cca34","volume":"18","author":"J Morrell","year":"2011","unstructured":"Morrell J, Zeymer U, Baumgartner I, Limbourg T, R\u00f6ther J, Bhatt DL, Steg PG, REACH Registry Investigators. Differences in management and outcomes between male and female patients with atherothrombotic disease: results from the REACH Registry in Europe. Eur J Cardiovasc Prev Rehabil. 2011;18(2):270\u20137.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"7","key":"454_CR8","doi-asserted-by":"publisher","first-page":"e001646","DOI":"10.1161\/JAHA.114.001646","volume":"4","author":"AL Beatty","year":"2015","unstructured":"Beatty AL, Ku IA, Bibbins-Domingo K, Christenson RH, DeFilippi CR, Ganz P, Ix JH, Lloyd-Jones D, Omland T, Sabatine MS, Schiller NB, Shlipak MG, Skali H, Takeuchi M, Vittinghoff E, Whooley MA. Traditional risk factors versus biomarkers for prediction of secondary events in patients with stable coronary heart disease: from the heart and soul study. J Am Heart Assoc. 2015;4(7):e001646.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"454_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1161\/CIRCULATIONAHA.109.919274","volume":"122","author":"A Goyal","year":"2010","unstructured":"Goyal A, Bhatt DL, Steg PG, Gersh BJ, Alberts MJ, Ohman EM, Corbal\u00e1n R, Eagle KA, Gaxiola E, Gao R, Goto S, D\u2019Agostino RB, Califf RM, Smith SC Jr, Wilson PW. Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries. Circulation. 2010;122(12):1167\u201375.","journal-title":"Circulation"},{"issue":"11","key":"454_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s10654-014-9961-9","volume":"29","author":"J Niedziela","year":"2014","unstructured":"Niedziela J, Hudzik B, Niedziela N, G\u0105sior M, Gierlotka M, Wasilewski J, Myrda K, Lekston A, Polo\u0144ski L, Rozentryt P. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29(11):801\u201312.","journal-title":"Eur J Epidemiol"},{"issue":"9536","key":"454_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0140-6736(06)69251-9","volume":"368","author":"A Romero-Corral","year":"2006","unstructured":"Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368(9536):666\u201378.","journal-title":"Lancet"},{"issue":"12","key":"454_CR12","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/jama.2010.1322","volume":"304","author":"DL Bhatt","year":"2010","unstructured":"Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM, Wilson PW, Alberts MJ, D\u2019Agostino R, Liau CS, Mas JL, R\u00f6ther J, Smith SC Jr, Salette G, Contant CF, Massaro JM, Steg PG, REACH Registry Investigators. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010;304(12):1350\u20137.","journal-title":"JAMA"},{"issue":"8","key":"454_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamainternmed.2016.2751","volume":"176","author":"M Leibowitz","year":"2016","unstructured":"Leibowitz M, Karpati T, Cohen-Stavi CJ, Feldman BS, Hoshen M, Bitterman H, Suissa S, Balicer RD. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic heart disease taking statin treatment. JAMA Intern Med. 2016;176(8):1105\u201313.","journal-title":"JAMA Intern Med"},{"issue":"8934","key":"454_CR14","first-page":"1383","volume":"344","author":"TR Pedersen","year":"1994","unstructured":"Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G, Py\u00f6r\u00e4l\u00e4 K, Miettinen T, Wilhelmsen L, Olsson AG, Wedel H, Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344(8934):1383\u20139.","journal-title":"Lancet"},{"issue":"7","key":"454_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrcardio.2011.58","volume":"8","author":"K Fox","year":"2011","unstructured":"Fox K, Ferrari R. Heart rate: a forgotten link in coronary artery disease? Nat Rev Cardiol. 2011;8(7):369\u201379.","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"454_CR16","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.amjcard.2009.11.035","volume":"105","author":"JE Ho","year":"2010","unstructured":"Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, Waters DD. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). Am J Cardiol. 2010;105(7):905\u201311.","journal-title":"Am J Cardiol"},{"issue":"12","key":"454_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","volume":"371","author":"K Fox","year":"2014","unstructured":"Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R, SIGNIFY Investigators. Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med. 2014;371(12):1091\u20139.","journal-title":"N Engl J Med"},{"issue":"9641","key":"454_CR18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","volume":"372","author":"K Fox","year":"2008","unstructured":"Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, BEAUTIFUL Investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet. 2008;372(9641):817\u201321.","journal-title":"Lancet"},{"issue":"1","key":"454_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2337\/dc07-1552","volume":"31","author":"M Wallander","year":"2008","unstructured":"Wallander M, Malmberg K, Norhammar A, Ryd\u00e9n L, Tenerz A. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study. Diabetes Care. 2008;31(1):36\u20138.","journal-title":"Diabetes Care"},{"issue":"1","key":"454_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/hrt.2005.086975","volume":"93","author":"M Bartnik","year":"2007","unstructured":"Bartnik M, Ryd\u00e9n L, Malmberg K, Ohrvik J, Py\u00f6r\u00e4l\u00e4 K, Standl E, Ferrari R, Simoons M, Soler-Soler J, Euro Heart Survey Investigators. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Heart. 2007;93(1):72\u20137.","journal-title":"Heart"},{"issue":"19","key":"454_CR21","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/eurheartj\/ehv008","volume":"36","author":"V Gyberg","year":"2015","unstructured":"Gyberg V, De Bacquer D, Kotseva K, De Backer G, Schnell O, Sundvall J, Tuomilehto J, Wood D, Ryd\u00e9n L, EUROASPIRE IV Investigators. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV\u2014a survey from the European Society of Cardiology. Eur Heart J. 2015;36(19):1171\u20137.","journal-title":"Eur Heart J"},{"issue":"8","key":"454_CR22","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1177\/2047487314547652","volume":"22","author":"R Ferrari","year":"2015","unstructured":"Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox K, Hu D, Shalnova S, Steg PG, CLARIFY Registry Investigators. Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry. Eur J Prev Cardiol. 2015;22(8):1056\u201365.","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"454_CR23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.ahj.2005.11.005","volume":"151","author":"JB Froehlich","year":"2006","unstructured":"Froehlich JB, Mukherjee D, Avezum A, Budaj A, Kline-Rogers EM, L\u00f3pez-Send\u00f3n J, Allegrone J, Eagle KA, Mehta RH, Goldberg RJ, GRACE Investigators. Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2006;151(5):1123\u20138.","journal-title":"Am Heart J"},{"issue":"2","key":"454_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ejvs.2008.02.004","volume":"36","author":"V Bertomeu","year":"2008","unstructured":"Bertomeu V, Morillas P, Gonzalez-Juanatey JR, Quiles J, Guindo J, Soria F, Llacer A, Lekuona I, Maz\u00f3n P, Mart\u00edn-Luengo C, Rodriguez-Padial L, Prevalence of Peripheral Arterial Disease in Patients with Acute Coronary S\u00edndrome (PAMISCA) Investigators. Prevalence and prognostic influence of peripheral arterial disease in patients\u2009>\u2009or\u2009=\u200940\u00a0years old admitted into hospital following an acute coronary event. Eur J Vasc Endovasc Surg. 2008;36(2):189\u201396.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"454_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.amjcard.2012.03.013","volume":"110","author":"F Bouisset","year":"2012","unstructured":"Bouisset F, Bongard V, Ruidavets JB, Hasco\u00ebt S, Taraszkiewicz D, Roncalli J, Carri\u00e9 D, Galinier M, Elbaz M, Ferri\u00e8res J. Prognostic usefulness of clinical and subclinical peripheral arterial disease in men with stable coronary heart disease. Am J Cardiol. 2012;110(2):197\u2013202.","journal-title":"Am J Cardiol"},{"issue":"13","key":"454_CR26","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMoa041365","volume":"351","author":"NS Anavekar","year":"2004","unstructured":"Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285\u201395.","journal-title":"N Engl J Med"},{"issue":"7555","key":"454_CR27","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1136\/bmj.38814.566019.2F","volume":"332","author":"M Tonelli","year":"2006","unstructured":"Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M, et al. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ. 2006;332(7555):1426.","journal-title":"BMJ"},{"issue":"7","key":"454_CR28","doi-asserted-by":"publisher","first-page":"e102335","DOI":"10.1371\/journal.pone.0102335","volume":"9","author":"PR Kalra","year":"2014","unstructured":"Kalra PR, Garc\u00eda-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG, CLARIFY Investigators. Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients. PLoS ONE. 2014;9(7):e102335.","journal-title":"PLoS ONE"},{"issue":"1","key":"454_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1681\/ASN.2006101112","volume":"19","author":"RT Domburg van","year":"2008","unstructured":"van Domburg RT, Hoeks SE, Welten GM, Chonchol M, Elhendy A, Poldermans D. Renal insufficiency and mortality in patients with known or suspected coronary artery disease. J Am Soc Nephrol. 2008;19(1):158\u201363.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"454_CR30","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/01.psy.0000146332.53619.b2","volume":"66","author":"J Barth","year":"2004","unstructured":"Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66(6):802\u201313.","journal-title":"Psychosom Med"},{"issue":"12","key":"454_CR31","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1161\/CIR.0000000000000019","volume":"129","author":"JH Lichtman","year":"2014","unstructured":"Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L, American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350\u201369.","journal-title":"Circulation"},{"issue":"12","key":"454_CR32","doi-asserted-by":"publisher","first-page":"e009128","DOI":"10.1136\/bmjopen-2015-009128","volume":"5","author":"PJ Tully","year":"2015","unstructured":"Tully PJ, Baumeister H. Collaborative care for comorbid depression and coronary heart disease: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2015;5(12):e009128.","journal-title":"BMJ Open"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-018-0454-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10654-018-0454-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-018-0454-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T09:46:22Z","timestamp":1571823982000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10654-018-0454-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["454"],"URL":"https:\/\/doi.org\/10.1007\/s10654-018-0454-0","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,23]]},"assertion":[{"value":"18 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"(1) KK, DDB, CJ, VG, LR and DW had grant support from the European Society of Cardiology for the submitted work; VG was supported by a Grant from the Swedish Heart and Lung Foundation; AP was supported by a grant from the Polish National Science Centre (Contract DEC-2011\/03\/B\/N27\/06101); JB was supported by the Grant No. NT 13186 by the Internal Grant Agency, Ministry of Health, Czech Republic; DM had grants from Servier, MSD, Sanofi-Aventis, Menarini; PA had grants from AstraZeneca; SS had grants from German Ministry of Research and Education via the Comprehensive Heart Failure Centre, University of W\u00fcrzburg; (2) DW, LR, KK, VG, PA, MD, MS, PH, RC, AE, DG, ZR, LT had the following financial activities outside the submitted work in the previous 3\u00a0years: DW, honoraria for invited lectures or advisory boards: AstraZeneca, Merck Sharp and Dohme, Kowa Pharmaceuticals, Menarini, Zentiva; consultancy: Merck Sharp and Dohme; LR, Grants from Swedish Heart Lung Foundation, Swedish Diabetes Association, Roche AG, Bayer AG and Karolinska Institute Funds, personal fees from Roche, SanofiAventis, and Bayer AG; KK, travel Grants from Roche and Boehringer Ingelheim; VG, lecture fees from MSD Sweden; PA had grants and personal fees from Fondation Plan Alzheimer, Servier, Alzprotect, Total, Hoffman Roche, Daichi Sankyo, Genoscreen; MD, grants from Universal Agency \u2018Profarma\u2019; MS was temporarily employed by MSD Sweden AB as Associate Director, medical affairs, during part of the study period; PH receives\/received in the recent years research support from the German Ministry of Research and Education (Centre for Stroke Research Berlin; Comprehensive Heart Failure Centre W\u00fcrzburg), the European Union (European Implementation Score Collaboration), the German Stroke Foundation, the Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, the Berlin Chamber of Physicians, and the University Hospital of W\u00fcrzburg; RC had grants from Krka, Novo Mesto, Slovenia, personal fees from Servier International, Medtronic, Medtronic Czechia, Abbott Products Operations AG, MSD Czech Republic, TEVA Pharmaceuticals Czech Republic; ZR had personal fees from Sanofi, AstraZeneca, Abbott, and Aegirion; AE had grants and personal fees from Abbott Vascular, Boston Scientific, Biosensors, Biotronik, Cordis J&J, Medtronik; DG had personal fees from AstraZaneca, Abbott, Novartis and Sanofi; LT had lecture honoraria from Abbott, MSD, Bayer, AstraZaneca, Boehringer Ingelheim, Pfizer, Sanofi, Servier, Kowa and Actelion, and (3) ACC, JWD, JDS, MD, ZF, DL, NG, AL, DL, EN, RO, NP, DV have no financial interests that are relevant to the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}